# Maragogipe Coffee (Coffea arabica)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/maragogipe-coffee
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-31
**Evidence Score:** 2 / 10
**Category:** Coffee Cultivars
**Also Known As:** Maragogipe Arabica, Elephant Bean Coffee, Large Bean Arabica, Maragogype Coffee, Brazilian Giant Bean, Typica Maragogipe, Coffea arabica var. Maragogipe

## Overview

Maragogipe is a large-bean Coffea arabica cultivar originating from Maragogipe, Brazil, containing caffeine (1.3–1.4%) and chlorogenic acids (primarily 5-caffeoylquinic acid) that contribute [antioxidant activity](/ingredients/condition/antioxidant). Its biochemical profile mirrors standard arabica coffee, though no cultivar-specific clinical trials have been conducted to distinguish its health effects from other arabica varieties.

## Health Benefits

• No clinical health benefits documented - research limited to compositional analysis only
• Contains caffeine (1.3-1.4%) - general coffee benefits may apply but not studied specifically for Maragogipe
• Contains chlorogenic acids (CQA isomers) - [antioxidant](/ingredients/condition/antioxidant) compounds present but clinical effects not evaluated
• Protein content (13%) and lipid content (6-8%) identified but nutritional benefits not clinically assessed
• Rich in volatile compounds contributing to sensory profile - no therapeutic effects studied

## Mechanism of Action

Caffeine in Maragogipe (1.3–1.4% dry weight) acts as a competitive antagonist at adenosine A1 and A2A receptors, inhibiting adenosine-mediated CNS depression and increasing [dopamine](/ingredients/condition/mood)rgic and noradrenergic neurotransmission. Chlorogenic acids, particularly 5-caffeoylquinic acid (5-CQA), inhibit glucose-6-phosphatase activity and scavenge [reactive oxygen species](/ingredients/condition/antioxidant) by donating hydrogen atoms to free radicals, reducing oxidative stress markers. These compounds also modulate NF-κB signaling pathways, potentially attenuating [pro-inflammatory cytokine](/ingredients/condition/inflammation) expression, though this has not been demonstrated in Maragogipe-specific research.

## Clinical Summary

No randomized controlled trials, observational studies, or pharmacokinetic studies have been conducted specifically on Maragogipe coffee as a distinct cultivar. Available data is limited to compositional analyses confirming caffeine content of 1.3–1.4% and the presence of CQA isomers comparable to other arabica varieties. General arabica coffee research — including large cohort studies such as the EPIC study involving over 500,000 participants — suggests associations between regular coffee consumption and reduced risk of type 2 diabetes and certain liver conditions, but these findings cannot be specifically attributed to Maragogipe. Evidence for this cultivar's distinct clinical efficacy is entirely absent, and any attributed benefits are extrapolated from the broader arabica coffee literature.

## Nutritional Profile

Maragogipe green coffee beans contain approximately 13% protein by dry weight, comprising essential amino acids including glutamic acid, aspartic acid, and leucine, though bioavailability is significantly altered by roasting. Lipid content ranges 6-8% dry weight, higher than typical Arabica varieties (12-16% of lipid fraction consists of diterpenes cafestol and kahweol, which are bioactive but also linked to [LDL cholesterol](/ingredients/condition/heart-health) elevation when unfiltered). Caffeine content measured at 1.3-1.4% dry weight, slightly lower than many Arabica cultivars, delivering approximately 80-100mg per standard 8oz brewed cup depending on roast and brewing method. Chlorogenic acid (CGA) complex is the dominant bioactive fraction, with 5-caffeoylquinic acid (5-CQA) as the primary isomer, alongside 3-CQA and 4-CQA; total CGA content estimated at 6-10% in green beans, degrading 50-70% upon roasting. Carbohydrate content approximately 60% dry weight, predominantly as polysaccharides (arabinogalactans, mannans) and sucrose (6-9% green bean), with sucrose largely degrading during roasting to form melanoidins. Trigonelline present at approximately 1% dry weight, partially converting to niacin (vitamin B3) during roasting, contributing an estimated 0.5-1mg niacin per cup. Mineral content includes potassium (approximately 1600-2000mg/100g dry green bean), magnesium (150-200mg/100g), calcium (100-130mg/100g), and trace manganese and zinc; mineral bioavailability in brewed coffee is moderate due to binding with polyphenols. No fiber is present in brewed coffee; insoluble fiber remains in spent grounds. Larger bean size of Maragogipe does not appear to significantly alter per-gram compositional ratios relative to standard Arabica, though lower planting density and slower maturation may subtly influence CGA and sucrose accumulation.

## Dosage & Preparation

No clinically studied dosage ranges have been established for Maragogipe coffee in any form (extract, powder, or standardized preparations), as no human trials exist. Compositional data indicates caffeine content of approximately 1.4% in green beans, but therapeutic doses have not been determined. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Maragogipe coffee carries the same safety considerations as standard arabica coffee, with caffeine doses above 400 mg/day (approximately 4 cups) associated with anxiety, [insomnia](/ingredients/condition/sleep), tachycardia, and elevated [blood pressure](/ingredients/condition/heart-health) in sensitive individuals. Caffeine is a known inhibitor of adenosine and interacts with medications including MAO inhibitors, anticoagulants such as warfarin (by affecting CYP1A2 [metabolism](/ingredients/condition/weight-management)), and stimulant drugs, potentially amplifying cardiovascular side effects. Pregnant individuals are advised to limit caffeine intake to under 200 mg/day per WHO guidelines, as higher doses are associated with low birth weight and preterm delivery risk. Individuals with cardiac arrhythmias, severe hypertension, anxiety disorders, or gastroesophageal reflux disease should exercise caution given caffeine's chronotropic and gastric acid-stimulating properties.

## Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses specific to Maragogipe coffee were identified in the available research. All existing studies focus exclusively on compositional analysis and sensory profiling rather than clinical health outcomes, with no PubMed PMIDs available for Maragogipe-specific therapeutic research.

## Historical & Cultural Context

No historical use in traditional medicine systems was documented for Maragogipe in the available research. The cultivar is primarily recognized in modern specialty coffee culture for its distinctive sensory qualities including sweetness, low acidity, and floral notes rather than any medicinal applications.

## Synergistic Combinations

Other arabica coffee cultivars, green tea extract, L-theanine, chlorogenic acid supplements, roasted coffee extracts

## Frequently Asked Questions

### What makes Maragogipe coffee different from other arabica varieties?

Maragogipe is distinguished primarily by its exceptionally large bean size — a natural mutation discovered in Maragogipe, Bahia, Brazil — rather than a substantially different chemical composition. Its caffeine content (1.3–1.4%) and chlorogenic acid profile are consistent with standard arabica cultivars, meaning no unique pharmacological advantage has been identified. The cultivar is valued commercially for cup quality and novelty rather than any documented superior health profile.

### Does Maragogipe coffee have more caffeine than regular coffee?

Maragogipe coffee contains approximately 1.3–1.4% caffeine by dry weight, which falls within the normal range for Coffea arabica and is not significantly higher than typical arabica varieties. Robusta species contain roughly double this amount (2.0–2.7%), making Maragogipe a moderate-caffeine option. A standard 8 oz brewed cup would yield roughly 80–120 mg of caffeine depending on brewing method and grind.

### Are there any clinical studies on Maragogipe coffee health benefits?

No clinical studies — including trials, cohort studies, or pharmacokinetic analyses — have been conducted specifically on Maragogipe coffee as a distinct cultivar. Existing research is limited to compositional and sensory analysis confirming its caffeine and chlorogenic acid content. Any health claims associated with Maragogipe are entirely extrapolated from the broader arabica and general coffee research literature.

### What antioxidants does Maragogipe coffee contain?

Maragogipe coffee contains chlorogenic acids, primarily 5-caffeoylquinic acid (5-CQA), which are the dominant antioxidant compounds in arabica coffee. These phenolic compounds scavenge reactive oxygen species and have been shown in general coffee research to reduce plasma oxidative stress markers. The specific concentrations of CQA isomers in Maragogipe have been confirmed present via compositional analysis, but cultivar-specific antioxidant capacity measurements have not been published in peer-reviewed literature.

### Is Maragogipe coffee safe to drink every day?

Daily consumption of Maragogipe coffee is generally safe for healthy adults within established caffeine guidelines of up to 400 mg/day (roughly 3–4 cups), consistent with guidance from the FDA and European Food Safety Authority. Individuals who are pregnant, have cardiovascular conditions, anxiety disorders, or take medications metabolized by CYP1A2 should consult a healthcare provider before regular consumption. No cultivar-specific safety concerns beyond standard arabica coffee have been identified for Maragogipe.

### Is Maragogipe coffee safe during pregnancy and breastfeeding?

Maragogipe coffee contains 1.3-1.4% caffeine, similar to standard arabica varieties, so general pregnancy caffeine guidelines apply—most medical authorities recommend limiting intake to under 200mg daily during pregnancy. Safety data specific to Maragogipe has not been studied, so pregnant and breastfeeding individuals should consult their healthcare provider and follow standard coffee consumption advice rather than assuming this cultivar differs in safety profile.

### Does Maragogipe coffee interact with medications?

Maragogipe coffee's caffeine content (1.3-1.4%) means it may interact with the same medications as regular coffee, including certain stimulants, blood pressure medications, and drugs metabolized by CYP1A2 enzymes. No cultivar-specific drug interaction studies exist for Maragogipe, so individuals taking medications should consult their pharmacist using standard coffee interaction guidelines rather than assuming this variety has a different safety profile.

### How much Maragogipe coffee should I drink daily for health benefits?

No clinical studies have established optimal dosing for Maragogipe coffee specifically, so recommendations must default to general arabica coffee guidance of 3-5 cups daily for most adults. Since clinical benefits have only been documented for coffee generically—not this cultivar—individual tolerance to its 1.3-1.4% caffeine content should guide personal consumption rather than expecting cultivar-specific dosing guidelines.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*